دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Issue Highlights
doi : 10.1016/S0360-3016(21)00136-X
OTHER CONTENTS| VOLUME 109, ISSUE 5, PA11-A12, APRIL 01, 2021
Reducing Radiation-Induced Cognitive Toxicity: Sparing the Hippocampus and Beyond
Kristin J. Redmond,Michael T. Milano,Michelle M. Kim,Daniel M. Trifiletti,Scott G. Soltys,Jona A. Hattangadi-Gluth
doi : 10.1016/j.ijrobp.2021.01.001
ONCOLOGY SCAN| VOLUME 109, ISSUE 5, P1131-1136, APRIL 01, 2021
A Histologic Low-Grade Glioma with 7 Gain, 10 Loss—A Wolf in Sheep’s Clothing
Erqi L. Pollom,Scott G. Soltys
doi : 10.1016/j.ijrobp.2019.11.018
GRAY ZONE| VOLUME 109, ISSUE 5, P1137-1138, APRIL 01, 2021
“All the Better to Treat You With…”
Glenn Bauman,David Macdonald
doi : 10.1016/j.ijrobp.2020.01.039
GRAY ZONE| VOLUME 109, ISSUE 5, P1139, APRIL 01, 2021
Sheep, Meet Stupp
Simon S. Lo,Eric L. Chang
doi : 10.1016/j.ijrobp.2020.01.038
GRAY ZONE| VOLUME 109, ISSUE 5, P1139-1140, APRIL 01, 2021
Stupp the Wolf
Benjamin A. Greenberger,Maria Werner-Wasik
doi : 10.1016/j.ijrobp.2020.07.2319
GRAY ZONE| VOLUME 109, ISSUE 5, P1140-1141, APRIL 01, 2021
Radiation Oncology in Colombia: An Opportunity for Improvement in the Postconflict Era
Maria Caicedo-Martinez,Benjamin Li,Alejandro Gonzalez-Motta,Ivan Bobadilla,Carolina Wiesner,Raul Murillo
doi : 10.1016/j.ijrobp.2020.12.006
AROUND THE GLOBE| VOLUME 109, ISSUE 5, P1142-1150, APRIL 01, 2021
Analysis of Patient-Reported Outcome Utilization Within National Clinical Trials Network Cooperative Group Radiation Oncology Trials Over the Past 2 Decades
Jackson N. Howell,Christopher J. Anker,Amanda J. Walker,Jennifer A. Dorth,Jordan R. Kharofa
doi : 10.1016/j.ijrobp.2020.12.007
TRIAL METHODOLOGY| VOLUME 109, ISSUE 5, P1151-1160, APRIL 01, 2021
Merit-Based Incentive Payment System (MIPS) Participation in Radiation Oncology Practices — A Simple Survey
Ryan T. Jones,Mary Jo Tarrant,Dominick Parris,Michael Ray,Join Y. Luh
doi : 10.1016/j.ijrobp.2020.11.001
HEALTH POLICY| VOLUME 109, ISSUE 5, P1161-1164, APRIL 01, 2021
Association Between Patient Education Videos and Knowledge of Radiation Treatment
Kiran A. Kumar,Katy E. Balazy,Paulina M. Gutkin,Jamie J. Karl,Rie von Eyben,Kathleen C. Horst
doi : 10.1016/j.ijrobp.2020.11.069
THE PATIENT EXPERIENCE| VOLUME 109, ISSUE 5, P1165-1175, APRIL 01, 2021
Is SABR Cost-Effective in Oligometastatic Cancer? An Economic Analysis of the SABR-COMET Randomized Trial
X. Melody Qu,Yujie Chen,Gregory S. Zaric,George B. Rodrigues,David A. Palma,Alexander V. Louie
doi : 10.1016/j.ijrobp.2020.12.001
CLINICAL INVESTIGATION| VOLUME 109, ISSUE 5, P1176-1184, APRIL 01, 2021
Cost-Effectiveness Analysis of Stereotactic Ablative Radiation Therapy in Patients With Oligometastatic Cancer
Abhishek Kumar,Christopher Straka,Patrick T. Courtney,Lucas Vitzthum,Paul Riviere,James D. Murphy
doi : 10.1016/j.ijrobp.2020.09.045
CLINICAL INVESTIGATION| VOLUME 109, ISSUE 5, P1185-1194, APRIL 01, 2021
Stereotactic Ablative Radiation Therapy to All Lesions in Patients With Oligometastatic Cancers: A Phase 1 Dose-Escalation Trial
Carole Mercier,Michaël Claessens,Andy Buys, MSc,Luc Dirix,Dirk Verellen,Piet Dirix
doi : 10.1016/j.ijrobp.2020.11.066
CLINICAL INVESTIGATION| VOLUME 109, ISSUE 5, P1195-1205, APRIL 01, 2021
Osteoradionecrosis: Exposing the Evidence Not the Bone
Andrew J. Frankart,Michael J. Frankart,Brian Cervenka,Alice L. Tang,Deepak G. Krishnan,Vinita Takiar
doi : 10.1016/j.ijrobp.2020.12.043
CLINICAL INVESTIGATION|CME| VOLUME 109, ISSUE 5, P1206-1218, APRIL 01, 2021
Impact of High-Dose-Rate and Low-Dose-Rate Brachytherapy Boost on Toxicity, Functional and Cancer Outcomes in Patients Receiving External Beam Radiation Therapy for Prostate Cancer: A National Population-Based Study
Matthew G. Parry,Julie Nossiter,Arunan Sujenthiran,Heather Payne,Jan van der Meulen,Ajay Aggarwal
doi : 10.1016/j.ijrobp.2020.11.023
CLINICAL INVESTIGATION| VOLUME 109, ISSUE 5, P1219-1229, APRIL 01, 2021
Brachytherapy Boost in Prostate Cancer: What Does Observational Data Add to the Debate?
Darren Mitchell,Suneil Jain
doi : 10.1016/j.ijrobp.2020.12.023
CLINICAL INVESTIGATION| VOLUME 109, ISSUE 5, P1230-1231, APRIL 01, 2021
Biochemical Control and Toxicity Outcomes of Stereotactic Body Radiation Therapy Versus Low-Dose-Rate Brachytherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer
Emile Gogineni,Zaker Rana,Danielle Soberman,Lucille Lee,Louis Potters,Bhupesh Parashar
doi : 10.1016/j.ijrobp.2020.11.003
CLINICAL INVESTIGATION| VOLUME 109, ISSUE 5, P1232-1242, APRIL 01, 2021
Prostate Bed Delineation Guidelines for Postoperative Radiation Therapy: On Behalf Of The Francophone Group of Urological Radiation Therapy
Sophie Robin,Marjory Jolicoeur,Samuel Palumbo,Stéphane Supiot,Corina Udrescu,Olivier Chapet
doi : 10.1016/j.ijrobp.2020.11.010
CLINICAL INVESTIGATION| VOLUME 109, ISSUE 5, P1243-1253, APRIL 01, 2021
Hypofractionated Postprostatectomy Radiation Therapy for Prostate Cancer to Reduce Toxicity and Improve Patient Convenience: A Phase 1/2 Trial
Nolan A. Wages,Jason C. Sanders,Amy Smith,...Tracey L. Krupski,Timothy J. Harris,Timothy N. Showalter
doi : 10.1016/j.ijrobp.2020.11.009
CLINICAL INVESTIGATION| VOLUME 109, ISSUE 5, P1254-1262, APRIL 01, 2021
Hypofractionated Radiation Therapy to the Prostate Bed With Intensity-Modulated Radiation Therapy (IMRT): A Phase 2 Trial
Elton Trigo Teixeira Leite,Clarissa Cerchi Angotti Ramos,Victor Augusto Bertotti Ribeiro,William Carlos Nahas,Jo?o Victor Salvajoli,Fabio Ynoe Moraes
doi : 10.1016/j.ijrobp.2020.12.020
CLINICAL INVESTIGATION| VOLUME 109, ISSUE 5, P1263-1270, APRIL 01, 2021
Combination of Radiation Therapy and Short-Term Androgen Blockade With Abiraterone Acetate Plus Prednisone for Men With High- and Intermediate-Risk Localized Prostate Cancer
Bridget F. Koontz,Karen E. Hoffman,Susan Halabi,Paul G. Corn,W. Robert Lee,Andrew J. Armstrong
doi : 10.1016/j.ijrobp.2020.11.059
CLINICAL INVESTIGATION| VOLUME 109, ISSUE 5, P1271-1278, APRIL 01, 2021
Factors Influencing Noncompletion of Radiation Therapy Among Men With Localized Prostate Cancer
Edward Christopher Dee,Vinayak Muralidhar,Melaku A. Arega,Nina N. Sanford,Paul L. Nguyen,Brandon A. Mahal
doi : 10.1016/j.ijrobp.2020.11.064
CLINICAL INVESTIGATION| VOLUME 109, ISSUE 5, P1279-1285, APRIL 01, 2021
Influence of Geography on Prostate Cancer Treatment
Chad Tang,Xiudong Lei,Grace L. Smith,Ya-Chen Tina Shih,Steven J. Frank,Benjamin D. Smith
doi : 10.1016/j.ijrobp.2020.11.055
CLINICAL INVESTIGATION| VOLUME 109, ISSUE 5, P1286-1295, APRIL 01, 2021
Once Daily Versus Twice Daily External Beam Accelerated Partial Breast Irradiation: A Randomized Prospective Study
Rimoun R. Boutrus,Sara El Sherif,Yasser Abdelazim,Ahmed Farahat,Tarek Hashem,Medhat El Sebaie
doi : 10.1016/j.ijrobp.2020.11.044
CLINICAL INVESTIGATION| VOLUME 109, ISSUE 5, P1296-1300, APRIL 01, 2021
Early Cardiac Effects of Contemporary Radiation Therapy in Patients With Breast Cancer
Suparna C. Clasen,Haochang Shou,Gary Freedman,Amanda M. Smith,Biniyam G. Demissei,Bonnie Ky
doi : 10.1016/j.ijrobp.2020.12.008
CLINICAL INVESTIGATION| VOLUME 109, ISSUE 5, P1301-1310, APRIL 01, 2021
Intensity Modulated Radiation Therapy (IMRT) With Simultaneously Integrated Boost Shortens Treatment Time and Is Noninferior to Conventional Radiation Therapy Followed by Sequential Boost in Adjuvant Breast Cancer Treatment: Results of a Large Randomized Phase III Trial (IMRT-MC2 Trial)
Juliane H?rner-Rieber,Tobias Forster,Adriane Hommertgen,Holger Hof,David Krug,Jürgen Debus
doi : 10.1016/j.ijrobp.2020.12.005
CLINICAL INVESTIGATION| VOLUME 109, ISSUE 5, P1311-1324, APRIL 01, 2021
Tumor-Infiltrating Lymphocytes in Low-Risk Patients With Breast Cancer Treated With Single-Dose Preoperative Partial Breast Irradiation
Jeanine E. Vasmel,Celien P.H. Vreuls,Quirine F. Manson,Paul J. van Diest,Helena M. Verkooijen,H.J.G. Desiree van den Bongard
doi : 10.1016/j.ijrobp.2020.12.009
CLINICAL INVESTIGATION| VOLUME 109, ISSUE 5, P1325-1331, APRIL 01, 2021
Locoregional Treatments and Ipsilateral Breast Cancer Recurrence Rates in BRCA1/2 Mutation Carriers
Rinat Bernstein-Molho,Yael Laitman,Shira Galper,Bella Kaufman,Eitan Friedman,Orit Kaidar-Person
doi : 10.1016/j.ijrobp.2020.11.058
CLINICAL INVESTIGATION| VOLUME 109, ISSUE 5, P1332-1340, APRIL 01, 2021
Isotoxic Intensity Modulated Radiation Therapy in Stage III Non-Small Cell Lung Cancer: A Feasibility Study
Kate Haslett,Neil Bayman,Kevin Franks,Fiona McDonald,W. David Ryder,Corinne Faivre-Finn
doi : 10.1016/j.ijrobp.2020.11.040
CLINICAL INVESTIGATION| VOLUME 109, ISSUE 5, P1341-1348, APRIL 01, 2021
Erlotinib Versus Etoposide/Cisplatin With Radiation Therapy in Unresectable Stage III Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Multicenter, Randomized, Open-Label, Phase 2 Trial
Ligang Xing,Gang Wu,Luhua Wang,Baolin Qu,Wanqi Zhu,Jinming Yu
doi : 10.1016/j.ijrobp.2020.11.026
CLINICAL INVESTIGATION| VOLUME 109, ISSUE 5, P1349-1358, APRIL 01, 2021
Concurrent Chemo-Proton Therapy Using Adaptive Planning for Unresectable Stage 3 Non-Small Cell Lung Cancer: A Phase 2 Study
Hiromitsu Iwata,Kenji Akita,Yusuke Yamaba,Toshiyuki Toshito,Hiroyuki Ogino,Yuta Shibamoto
doi : 10.1016/j.ijrobp.2020.11.035
CLINICAL INVESTIGATION| VOLUME 109, ISSUE 5, P1359-1367, APRIL 01, 2021
Radical Hemithoracic Radiotherapy Versus Palliative Radiotherapy in Non-metastatic Malignant Pleural Mesothelioma: Results from a Phase 3 Randomized Clinical Trial
Marco Trovo,Alberto Relevant,Jerry Polesel,Paolo Fontana,Giovanni Franchin,Emilio Minatel
doi : 10.1016/j.ijrobp.2020.11.057
CLINICAL INVESTIGATION| VOLUME 109, ISSUE 5, P1368-1376, APRIL 01, 2021
The Dutch–Belgian Registry of Stereotactic Body Radiation Therapy for Liver Metastases: Clinical Outcomes of 515 Patients and 668 Metastases
Alejandra Méndez Romero,Wilco Schillemans,Rob van Os,Merel S. Koedijk,Ben J.M. Heijmen,Jeroen Buijsen
doi : 10.1016/j.ijrobp.2020.11.045
CLINICAL INVESTIGATION| VOLUME 109, ISSUE 5, P1377-1386, APRIL 01, 2021
Long-Term Results of a Phase 1 Dose-Escalation Trial and Subsequent Institutional Experience of Single-Fraction Stereotactic Ablative Radiation Therapy for Liver Metastases
Michael R. Folkert,Jeffrey J. Meyer,Todd A. Aguilera,Raquibul Hannan,Lucien A. Nedzi,Robert D. Timmerman
doi : 10.1016/j.ijrobp.2020.12.012
CLINICAL INVESTIGATION| VOLUME 109, ISSUE 5, P1387-1395, APRIL 01, 2021
Stereotactic Body Radiation Therapy for Metastatic and Recurrent Solid Tumors in Children and Young Adults
Christopher L. Tinkle,Charu Singh,Shane Lloyd,Stephanie A. Terezakis,Steve E. Braunstein,Matthew J. Krasin
doi : 10.1016/j.ijrobp.2020.11.054
CLINICAL INVESTIGATION| VOLUME 109, ISSUE 5, P1396-1405, APRIL 01, 2021
Local Control After Proton Therapy for Pediatric Chordoma
Daniel J. Indelicato,Ronny L. Rotondo,Raymond B. Mailhot Vega,Eric S. Sandler,Philipp R. Aldana,Julie A. Bradley
doi : 10.1016/j.ijrobp.2020.11.051
CLINICAL INVESTIGATION| VOLUME 109, ISSUE 5, P1406-1413, APRIL 01, 2021
A Prospective Trial of Radiation Therapy Efficacy and Toxicity for Localized Mucosa-associated Lymphoid Tissue (MALT) Lymphoma
Penny Fang,Jillian R. Gunther,Chelsea C. Pinnix,Sattva Neelapu,Chul S. Ha,Bouthaina S. Dabaja
doi : 10.1016/j.ijrobp.2020.11.070
CLINICAL INVESTIGATION| VOLUME 109, ISSUE 5, P1414-1420, APRIL 01, 2021
Toxicity of L19-Interleukin 2 Combined with Stereotactic Body Radiation Therapy: A Phase 1 Study
Evert Jan Van Limbergen,Ann Hoeben,Relinde I.Y. Lieverse,Dirk De Ruysscher,Esther G.C. Troost,Philippe Lambin
doi : 10.1016/j.ijrobp.2020.11.053
CLINICAL INVESTIGATION| VOLUME 109, ISSUE 5, P1421-1430, APRIL 01, 2021
Quality of Life: A Prospective Randomized Trial of Palliative Volumetric Arc Therapy Versus 3-Dimensional Conventional Radiation Therapy
Philip Wong,Louise Lambert,Phengsavanh Thanomsack,Israel Fortin,Julie Lafontaine,David Roberge
doi : 10.1016/j.ijrobp.2020.11.061
CLINICAL INVESTIGATION| VOLUME 109, ISSUE 5, P1431-1439, APRIL 01, 2021
Effects of Ultra-high doserate FLASH Irradiation on the Tumor Microenvironment in Lewis Lung Carcinoma: Role of Myosin Light Chain
Young-Eun Kim,Seung-Hee Gwak,Beom-Ju Hong,Peter G. Maxim,Billy W. Loo Jr.,G-One Ahn
doi : 10.1016/j.ijrobp.2020.11.012
BIOLOGY CONTRIBUTION| VOLUME 109, ISSUE 5, P1440-1453, APRIL 01, 2021
Mithramycin A Radiosensitizes EWS:Fli1+ Ewing Sarcoma Cells by Inhibiting Double Strand Break Repair
Mei Yun Lin,Timothy A. Damron,Megan E. Oest,Jason A. Horton
doi : 10.1016/j.ijrobp.2020.12.010
BIOLOGY CONTRIBUTION| VOLUME 109, ISSUE 5, P1454-1471, APRIL 01, 2021
Ultrasound-Mediated Gemcitabine Delivery Reduces the Normal-Tissue Toxicity of Chemoradiation Therapy in a Muscle-Invasive Bladder Cancer Model
Jia-Ling Ruan,Richard J. Browning,Yesna O. Yildiz,Borivoj Vojnovic,Eleanor Stride,Anne E. Kiltie
doi : 10.1016/j.ijrobp.2020.11.046
BIOLOGY CONTRIBUTION| VOLUME 109, ISSUE 5, P1472-1482, APRIL 01, 2021
Localized Delivery of Cisplatin to Cervical Cancer Improves Its Therapeutic Efficacy and Minimizes Its Side Effect Profile
Cinzia Federico,Jennifer Sun,Barbara Muz,Perry Grigsby,Julie K. Schwarz,Abdel Kareem Azab
doi : 10.1016/j.ijrobp.2020.11.052
BIOLOGY CONTRIBUTION| VOLUME 109, ISSUE 5, P1483-1494, APRIL 01, 2021
Microsecond Pulsed Electric Fields: An Effective Way to Selectively Target and Radiosensitize Medulloblastoma Cancer Stem Cells
Mirella Tanori,Arianna Casciati,Alessandro Zambotti,Carmela Marino,Mariateresa Mancuso,Caterina Merla
doi : 10.1016/j.ijrobp.2020.11.047
BIOLOGY CONTRIBUTION| VOLUME 109, ISSUE 5, P1495-1507, APRIL 01, 2021
NF-?B Blockade by NEMO Binding Domain Peptide Ameliorates Inflammation and Neurobehavioral Sequelae After Cranial Radiation Therapy in Juvenile Mice
Christine A. Beamish,Janice A. Zawaski,Taeko Inoue,David R. Grosshans,Omaima M. Sabek,M. Waleed Gaber
doi : 10.1016/j.ijrobp.2020.11.067
BIOLOGY CONTRIBUTION| VOLUME 109, ISSUE 5, P1508-1520, APRIL 01, 2021
Dose Fractionation During Puberty Is More Detrimental to Mammary Gland Development Than an Equivalent Acute Dose of Radiation Exposure
Brandi Wiedmeyer,Jennifer To,Deepa. M. Sridharan,Antoine M. Snijders,Hidetoshi Mori,Janice M. Pluth
doi : 10.1016/j.ijrobp.2020.11.039
BIOLOGY CONTRIBUTION| VOLUME 109, ISSUE 5, P1521-1532, APRIL 01, 2021
Polymorphonuclear-MDSCs Facilitate Tumor Regrowth After Radiation by Suppressing CD8+ T Cells
Jieying Zhang, MD,Liling Zhang, MD,Yuhui Yang, MD,Zihan Xia, MD,Tao Liu, MD,Gang Wu, MD
doi : 10.1016/j.ijrobp.2020.11.038
BIOLOGY CONTRIBUTION| VOLUME 109, ISSUE 5, P1533-1546, APRIL 01, 2021
Role of Myeloid-Derived Suppressor Cells in High-Dose-Irradiated TRAMP-C1 Tumors: A Therapeutic Target and an Index for Assessing Tumor Microenvironment
Sheng-Yung Fu,Fang-Hsin Chen,Chun-Chieh Wang,Ching-Fang Yu,Chi-Shiun Chiang,Ji-Hong Hong
doi : 10.1016/j.ijrobp.2020.11.004
BIOLOGY CONTRIBUTION| VOLUME 109, ISSUE 5, P1547-1558, APRIL 01, 2021
Effect of Interleukin-7 on Radiation-Induced Lymphopenia and Its Antitumor Effects in a Mouse Model
Hwa Kyung Byun,Kyoung-Jin Kim,Su Chul Han,Jinsil Seong
doi : 10.1016/j.ijrobp.2020.12.004
BIOLOGY CONTRIBUTION| VOLUME 109, ISSUE 5, P1559-1569, APRIL 01, 2021
Effects From Nonuniform Dose Distribution in the Spinal Nerves of Pigs: Analysis of Normal Tissue Complication Probability Models
Brian Hrycushko,Paul M. Medin
doi : 10.1016/j.ijrobp.2020.11.002
BIOLOGY CONTRIBUTION| VOLUME 109, ISSUE 5, P1570-1579, APRIL 01, 2021
Dosimetric Impact of Intrafraction Motion in Online-Adaptive Intensity Modulated Proton Therapy for Cervical Cancer
Thomas Berger,Jérémy Godart,Thyrza Jagt,Petra Trnkova,Kari Tanderup,Mischa Hoogeman
doi : 10.1016/j.ijrobp.2020.11.037
PHYSICS CONTRIBUTION| VOLUME 109, ISSUE 5, P1580-1587, APRIL 01, 2021
Quantification of Intrafraction and Interfraction Tumor Motion Amplitude and Prediction Error for Different Liver Tumor Trajectories in Cyberknife Synchrony Tracking
Jianping Zhang,Lin Wang,Xiaobo Li,Miaoyun Huang,Benhua Xu
doi : 10.1016/j.ijrobp.2020.11.036
PHYSICS CONTRIBUTION| VOLUME 109, ISSUE 5, P1588-1605, APRIL 01, 2021
Initial Feasibility and Clinical Implementation of Daily MR-Guided Adaptive Head and Neck Cancer Radiation Therapy on a 1.5T MR-Linac System: Prospective R-IDEAL 2a/2b Systematic Clinical Evaluation of Technical Innovation
Brigid A. McDonald,Sastry Vedam,Jinzhong Yang,John Christodouleas,Clifton D. FullerOn Behalf of the MR-Linac Consortium Head and Neck Tumor Site Group
doi : 10.1016/j.ijrobp.2020.12.015
PHYSICS CONTRIBUTION| VOLUME 109, ISSUE 5, P1606-1618, APRIL 01, 2021
Using Auto-Segmentation to Reduce Contouring and Dose Inconsistency in Clinical Trials: The Simulated Impact on RTOG 0617
Maria Thor,Aditya Apte,Rabia Haq,Aditi Iyer,Eve LoCastro,Joseph O. Deasy
doi : 10.1016/j.ijrobp.2020.11.011
PHYSICS CONTRIBUTION| VOLUME 109, ISSUE 5, P1619-1626, APRIL 01, 2021
Initial Clinical Experience of Cherenkov Imaging in External Beam Radiation Therapy Identifies Opportunities to Improve Treatment Delivery
Lesley A. Jarvis,Rachael L. Hachadorian,Michael Jermyn,Philip E. Schaner,Bassem I. Zaki,Brian W. Pogue
doi : 10.1016/j.ijrobp.2020.11.013
PHYSICS CONTRIBUTION| VOLUME 109, ISSUE 5, P1627-1637, APRIL 01, 2021
New Data-Driven Gated PET/CT Free of Misregistration Artifacts
Tinsu Pan,Yang Lu,M. Allan Thomas,Zhongxing Liao,Dershan Luo
doi : 10.1016/j.ijrobp.2020.11.014
PHYSICS CONTRIBUTION| VOLUME 109, ISSUE 5, P1638-1646, APRIL 01, 2021
Integration of Risk Survival Measures Estimated From Pre- and Posttreatment Computed Tomography Scans Improves Stratification of Patients With Early-Stage Non-small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy
Zhicheng Jiao,Hongming Li,Ying Xiao,Steven J. Feigenberg,Gary D. Kao,Yong Fan
doi : 10.1016/j.ijrobp.2020.12.014
PHYSICS CONTRIBUTION| VOLUME 109, ISSUE 5, P1647-1656, APRIL 01, 2021
Posterior Margins in Prostate Cancer Radiation Therapy
Hideya Yamazaki,Gen Suzuki,Norihiro Aibe,Ken Yoshida,Satoaki Nakamura
doi : 10.1016/j.ijrobp.2020.11.050
COMMENTS| VOLUME 109, ISSUE 5, P1657-1658, APRIL 01, 2021
In Regard to Helm et al
Aysenur Elmali,Melek Tugce Yilmaz,Gozde Yazici
doi : 10.1016/j.ijrobp.2020.12.017
COMMENTS| VOLUME 109, ISSUE 5, P1658, APRIL 01, 2021
In Reply to Elmali et al
Alexander Helm,Walter Tinganelli,Claudia Fournier,Palma Simoniello,Fuki Kurosawa,Takashi Shimokawa,Marco Durante
doi : 10.1016/j.ijrobp.2020.12.016
COMMENTS| VOLUME 109, ISSUE 5, P1658-1659, APRIL 01, 2021
In Regard to Rowley et al
Gavin P. Jones,Trevor J. Royce,Mudit Chowdhary
doi : 10.1016/j.ijrobp.2020.11.071
COMMENTS| VOLUME 109, ISSUE 5, P1659-1660, APRIL 01, 2021
In Reply to Jones et al
Jared P. Rowley,Kunal K. Sindhu,William H. Smith,Eric J. Lehrer,Michael Buckstein,Stanislav Lazarev
doi : 10.1016/j.ijrobp.2020.11.072
COMMENTS| VOLUME 109, ISSUE 5, P1660-1661, APRIL 01, 2021
Meetings
doi : 10.1016/S0360-3016(21)00137-1
ANNOUNCEMENT| VOLUME 109, ISSUE 5, P1662, APRIL 01, 2021
